| Financial Year |
March 31 2023 |
| Monetary Funds |
469,256,829.17 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
566,173,747.71 |
| Advances to Suppliers |
13,936,438.75 |
| Other Receivables |
18,866,085.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
36,867,066.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
548,504.77 |
| Other Current Assets |
59,800,706.35 |
| Total Current Assets |
1,274,087,200.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,147,606.55 |
| Long-term Equity Investment |
197,827,719.05 |
| Investment Properties |
16,726,320.84 |
| Fixed Assetes |
791,565,039.99 |
| Under-construction Projects |
24,505,459.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,122,326,443.75 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,356,480.82 |
| Deferred Income Tax Assets |
49,777,221.75 |
| Other Non-Current Assets |
34,190,189.70 |
| Sub-Total of Non-Current Assets |
4,513,165,637.10 |
| Total Assets |
5,787,252,837.18 |
| Short-Term Loans |
271,933,909.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,254,226.80 |
| Accounts Payable |
590,810,723.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,729,880.53 |
| Taxes Payable |
31,868,188.18 |
| Interest Payable |
370,209.00 |
| Dividend Payable |
-- |
| Other payables |
155,647,574.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
229,611,701.50 |
| Other Current Liabilities |
807,374.10 |
| Sub-Total of Current Liabilities |
1,418,987,158.52 |
| Long-term Loans |
1,679,614,519.80 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
581,640.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
171,169,563.18 |
| Deferred Income Tax Liabilities |
10,402,598.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,919,952,515.25 |
| Total Liabilities |
3,338,939,673.77 |
| Paid-In Capital(Or Share Stock) |
461,760,000.00 |
| Capital Surplus |
911,391,271.38 |
| Surplus Reserve |
73,520,580.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
899,241,302.65 |
| Minority Stockholder's Interest |
102,400,008.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,345,913,154.75 |
| Owner's Equity（Stockholder's Equity） |
2,448,313,163.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,787,252,837.18 |
